Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.3 USD | -0.22% |
|
-4.15% | -24.39% |
01/07 | RBC Lowers Price Target on Illumina to $242 From $249, Keeps Outperform Rating | MT |
01/07 | ANALYST RECOMMENDATIONS : Nvidia, Broadcom, Progressive, Draftkings, Moody's... | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.39% | 1.68TCr | |
+0.91% | 20TCr | |
+3.74% | 18TCr | |
+28.89% | 16TCr | |
+31.66% | 11TCr | |
+1.18% | 6.43TCr | |
+19.45% | 5.5TCr | |
-3.44% | 4.74TCr | |
-9.28% | 3.67TCr | |
-0.10% | 3.48TCr |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- Transcript : Illumina Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-08-2013 08